1. Home
  2. ITCI vs CGNX Comparison

ITCI vs CGNX Comparison

Compare ITCI & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • CGNX
  • Stock Information
  • Founded
  • ITCI 2002
  • CGNX 1981
  • Country
  • ITCI United States
  • CGNX United States
  • Employees
  • ITCI N/A
  • CGNX N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • CGNX Industrial Machinery/Components
  • Sector
  • ITCI Health Care
  • CGNX Industrials
  • Exchange
  • ITCI Nasdaq
  • CGNX Nasdaq
  • Market Cap
  • ITCI 8.0B
  • CGNX 6.9B
  • IPO Year
  • ITCI N/A
  • CGNX 1989
  • Fundamental
  • Price
  • ITCI $86.40
  • CGNX $40.71
  • Analyst Decision
  • ITCI Strong Buy
  • CGNX Buy
  • Analyst Count
  • ITCI 12
  • CGNX 12
  • Target Price
  • ITCI $97.00
  • CGNX $48.58
  • AVG Volume (30 Days)
  • ITCI 459.9K
  • CGNX 1.0M
  • Earning Date
  • ITCI 10-30-2024
  • CGNX 10-30-2024
  • Dividend Yield
  • ITCI N/A
  • CGNX 0.74%
  • EPS Growth
  • ITCI N/A
  • CGNX N/A
  • EPS
  • ITCI N/A
  • CGNX 0.45
  • Revenue
  • ITCI $564,526,000.00
  • CGNX $844,000,000.00
  • Revenue This Year
  • ITCI $46.60
  • CGNX $10.64
  • Revenue Next Year
  • ITCI $37.06
  • CGNX $12.99
  • P/E Ratio
  • ITCI N/A
  • CGNX $90.38
  • Revenue Growth
  • ITCI 54.31
  • CGNX N/A
  • 52 Week Low
  • ITCI $46.10
  • CGNX $34.28
  • 52 Week High
  • ITCI $84.89
  • CGNX $53.13
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 73.36
  • CGNX 57.57
  • Support Level
  • ITCI $75.57
  • CGNX $38.42
  • Resistance Level
  • ITCI $79.46
  • CGNX $40.70
  • Average True Range (ATR)
  • ITCI 2.42
  • CGNX 0.88
  • MACD
  • ITCI 0.60
  • CGNX 0.10
  • Stochastic Oscillator
  • ITCI 88.13
  • CGNX 83.27

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: